Cas no 65858-50-6 (5-(Bromomethyl)-2,1,3-benzothiadiazole)
5-(Bromomethyl)-2,1,3-benzothiadiazole Chemical and Physical Properties
Names and Identifiers
-
- 5-(Bromomethyl)benzo[c][1,2,5]thiadiazole
- 5-(BROMOMETHYL)-2,1,3-BENZOTHIADIAZOLE
- BUTTPARK 75\50-31
- 5-(BroMoMethyl)benzo-2,1,3-thiadiazole
- 2,1,3-Benzothiadiazole,5-(bromomethyl)-
- 5-(bromomethyl)2,1,3-benzothiadiazole
- 5-Brommethyl-benzo[1,2,5]thiadiazol
- 5-bromomethyl-benzo[1,2,5]thiadiazole
- 5-bromomethylbenzo-2,1,3-thiadiazole
- benzo[c][1,2,5]thiadiazol-5-yl-methylbromide
- (benzo-[c][1,2,5]-thiadiazol-6-yl)methylbromide
- 5-(BROMOMETHYL)-2,1,3-BENZOTHIADIAZOLE;BUTTPARK 75\\50-31;5-(Bromomethyl)-2,1,3-benzothiadiazole, 95+%;5-(bromomethyl)benzo[c][1,2,5]thiadiazole;5-(BroMoMethyl)benzo-2,1,3-thiadiazole
- A867582
- HMS1375B01
- 5-bromomethylbenzo-2.1.3-thiadiazole
- 5-bromomethylbenzo[2,1,3]thiadiazole
- 65858-50-6
- AKOS003286244
- ChemDiv2_002135
- EN300-208105
- J-516297
- SCHEMBL245270
- EU-0019145
- FT-0619693
- DTXSID80343624
- GA-0867
- 2,1,3-Benzothiadiazole, 5-(bromomethyl)-
- 2,1,3-Benzothiadiazole, 5-bromomethyl-
- MFCD00544836
- AMY9213
- 5-(Bromomethyl)-2,1,3-benzothiadiazole #
- s12027
- STK734233
- DB-010938
- ALBB-023063
- 5-(Bromomethyl)-2,1,3-benzothiadiazole
-
- MDL: MFCD00544836
- Inchi: 1S/C7H5BrN2S/c8-4-5-1-2-6-7(3-5)10-11-9-6/h1-3H,4H2
- InChI Key: JEPACAAYCVWCFI-UHFFFAOYSA-N
- SMILES: BrCC1C=CC2C(C=1)=NSN=2
Computed Properties
- Exact Mass: 227.93600
- Monoisotopic Mass: 227.93568g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 11
- Rotatable Bond Count: 1
- Complexity: 144
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.4
- Topological Polar Surface Area: 54?2
Experimental Properties
- Density: 1.776
- Melting Point: 91 °C
- Boiling Point: 299.3°C at 760 mmHg
- Flash Point: 134.8°C
- Refractive Index: 1.726
- PSA: 54.02000
- LogP: 2.58620
5-(Bromomethyl)-2,1,3-benzothiadiazole Security Information
- Hazard Statement: Corrosive
- Hazard Category Code: 20/21/22-36/37/38
- Safety Instruction: S26-S36/37/39-S45
-
Hazardous Material Identification:
- Safety Term:S26;S36/37/39;S45
- HazardClass:IRRITANT
- Risk Phrases:R34
5-(Bromomethyl)-2,1,3-benzothiadiazole Customs Data
- HS CODE:2934999090
- Customs Data:
China Customs Code:
2934999090Overview:
2934999090. Other heterocyclic compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to
Summary:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5-(Bromomethyl)-2,1,3-benzothiadiazole Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A019096548-1g |
5-(Bromomethyl)benzo[c][1,2,5]thiadiazole |
65858-50-6 | 95% | 1g |
$198.72 | 2023-09-01 | |
| Alichem | A019096548-5g |
5-(Bromomethyl)benzo[c][1,2,5]thiadiazole |
65858-50-6 | 95% | 5g |
$445.12 | 2023-09-01 | |
| Chemenu | CM153557-5g |
5-(Bromomethyl)-2,1,3-benzothiadiazole |
65858-50-6 | 95% | 5g |
$496 | 2021-06-09 | |
| TRC | B697075-100mg |
5-(Bromomethyl)-2,1,3-benzothiadiazole |
65858-50-6 | 100mg |
$ 69.00 | 2023-04-18 | ||
| TRC | B697075-250mg |
5-(Bromomethyl)-2,1,3-benzothiadiazole |
65858-50-6 | 250mg |
$ 133.00 | 2023-04-18 | ||
| TRC | B697075-500mg |
5-(Bromomethyl)-2,1,3-benzothiadiazole |
65858-50-6 | 500mg |
$ 196.00 | 2023-04-18 | ||
| TRC | B697075-1g |
5-(Bromomethyl)-2,1,3-benzothiadiazole |
65858-50-6 | 1g |
$ 282.00 | 2023-04-18 | ||
| Fluorochem | 217641-1g |
5-(Bromomethyl)benzo[c][1,2,5]thiadiazole |
65858-50-6 | 95% | 1g |
£205.00 | 2022-03-01 | |
| Apollo Scientific | OR23129-250mg |
5-(Bromomethyl)-2,1,3-benzothiadiazole |
65858-50-6 | 250mg |
£40.00 | 2025-02-19 | ||
| Apollo Scientific | OR23129-1g |
5-(Bromomethyl)-2,1,3-benzothiadiazole |
65858-50-6 | 1g |
£100.00 | 2025-02-19 |
5-(Bromomethyl)-2,1,3-benzothiadiazole Related Literature
-
Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
-
Shivani Sharma,Chia-Ming Wu,Ranjit T. Koodali,N. Rajesh RSC Adv., 2016,6, 26668-26678
-
Fuming Xiao,Mengzhu Wang,Yunxiang Lei,Wenbo Dai,Yunbing Zhou,Miaochang Liu,Wenxia Gao,Xiaobo Huang,Huayue Wu J. Mater. Chem. C, 2020,8, 17410-17416
-
Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
Additional information on 5-(Bromomethyl)-2,1,3-benzothiadiazole
5-(Bromomethyl)-2,1,3-benzothiadiazole (CAS No. 65858-50-6): A Comprehensive Overview
5-(Bromomethyl)-2,1,3-benzothiadiazole (CAS No. 65858-50-6) is a specialized organic compound that has garnered significant attention in the fields of pharmaceuticals, agrochemicals, and materials science. This benzothiadiazole derivative is characterized by its unique molecular structure, which combines a bromomethyl functional group with a benzothiadiazole core. The compound's versatility and reactivity make it a valuable intermediate in synthetic chemistry, particularly in the development of novel bioactive molecules and functional materials.
The growing interest in 5-(Bromomethyl)-2,1,3-benzothiadiazole is driven by its potential applications in drug discovery and materials engineering. Researchers are increasingly exploring its use as a building block for the synthesis of heterocyclic compounds, which are pivotal in the design of new therapeutic agents. The benzothiadiazole moiety, in particular, is known for its electron-withdrawing properties, making it a key component in the development of organic semiconductors and photovoltaic materials. This aligns with the current global focus on sustainable energy solutions and advanced materials for renewable energy applications.
From a chemical perspective, 5-(Bromomethyl)-2,1,3-benzothiadiazole exhibits notable reactivity due to the presence of the bromomethyl group. This functional group serves as an excellent leaving group in nucleophilic substitution reactions, enabling the introduction of various substituents onto the benzothiadiazole scaffold. Such transformations are crucial for tailoring the compound's properties to meet specific application requirements. For instance, in medicinal chemistry, this reactivity can be harnessed to create derivatives with enhanced pharmacokinetic profiles or targeted biological activities.
The synthesis of 5-(Bromomethyl)-2,1,3-benzothiadiazole typically involves the bromination of the corresponding methyl derivative under controlled conditions. This process highlights the importance of precise reaction control to achieve high yields and purity, which are critical for its subsequent applications. Analytical techniques such as NMR spectroscopy, mass spectrometry, and HPLC are commonly employed to characterize and validate the compound's structure and purity, ensuring its suitability for advanced research and industrial use.
In the pharmaceutical industry, 5-(Bromomethyl)-2,1,3-benzothiadiazole is explored for its potential role in the development of antiviral and anticancer agents. The benzothiadiazole core is known to interact with various biological targets, making it a promising scaffold for drug design. Recent studies have investigated its derivatives as inhibitors of specific enzymes or receptors, addressing unmet medical needs in areas such as oncology and infectious diseases. This aligns with the increasing demand for innovative therapies and personalized medicine.
Beyond pharmaceuticals, 5-(Bromomethyl)-2,1,3-benzothiadiazole finds applications in agrochemicals, where it serves as a precursor for the synthesis of herbicides and fungicides. The compound's ability to modulate biological pathways in plants makes it a valuable tool for crop protection and yield enhancement. With the global agricultural sector facing challenges such as pest resistance and climate change, the development of new agrochemicals based on benzothiadiazole derivatives is a key area of research.
In materials science, the electron-deficient nature of the benzothiadiazole ring makes 5-(Bromomethyl)-2,1,3-benzothiadiazole a candidate for organic electronic devices. Researchers are investigating its incorporation into polymers and small molecules for use in organic light-emitting diodes (OLEDs), organic photovoltaics (OPVs), and field-effect transistors (OFETs). These applications are particularly relevant in the context of the ongoing push for greener technologies and energy-efficient devices.
The market for 5-(Bromomethyl)-2,1,3-benzothiadiazole is expected to grow in tandem with advancements in these fields. Suppliers and manufacturers are focusing on scaling up production while maintaining high purity standards to meet the demands of academic and industrial researchers. Quality control and regulatory compliance are paramount, ensuring that the compound is available for safe and effective use across various applications.
In summary, 5-(Bromomethyl)-2,1,3-benzothiadiazole (CAS No. 65858-50-6) is a multifaceted compound with broad utility in pharmaceuticals, agrochemicals, and materials science. Its unique structural features and reactivity profile make it a valuable asset in synthetic chemistry, driving innovation across multiple industries. As research continues to uncover new applications and derivatives, this compound is poised to play an increasingly important role in addressing contemporary scientific and technological challenges.
65858-50-6 (5-(Bromomethyl)-2,1,3-benzothiadiazole) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)